Mayo Clinic researchers will present over 30 studies at ASCO 2026, highlighting new advances in imaging AI, data science, and early cancer detection.
Key Details
- 1More than 30 Mayo Clinic studies will be featured at the 2026 ASCO Annual Meeting.
- 2Highlighted topics include precision oncology, early cancer detection, and AI-driven analysis.
- 3A deep learning approach will be presented to quantify tumor microenvironment features in colon cancer trials.
- 4Research includes multicancer early detection testing and biomarker-driven treatments for various cancers.
- 5Specific sessions will address AI-enabled analysis of postoperative ctDNA status and clinical outcomes.
Why It Matters
Presentations on AI-powered tissue analysis and early detection signal accelerating integration of imaging AI into oncology care. Such advances can inform best practices for radiologists and collaborative cancer care teams.
Source
EurekAlert
Related News
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.
•EurekAlert
ACM Honors 3D Generative AI and NeRF Innovators With Technical Awards
ACM recognized researchers for breakthroughs in wireless standards, artificial intelligence, and 3D generative AI, including major advances in neural radiance fields impacting computer vision and medical imaging.
•EurekAlert
Ultrasound-Guided Nerve Freezing Revolutionizes Pediatric Ear Surgery Recovery
Lurie Children’s Hospital pioneers ultrasound-guided nerve freezing to eliminate prolonged postoperative pain in microtia repair.